CAMERA Newsletters

In this edition, we explore practical ways to support someone living with dementia, how common over-the-counter medications may affect brain health, and the differences between Parkinson’s disease and Lewy body dementia. We also highlight the importance of healthy blood vessels in maintaining brain health as we age.

The CAMERA Study continues to advance our understanding of dementia risk across diverse populations in Canada. This issue highlights our first publication, updates to the study schedule, and exciting new imaging capabilities with Sunnybrook’s 7T MRI scanner. We also explore emerging research on early brain changes, including the role of the blood–brain barrier and innovative, less invasive diagnostic approaches.

Health Canada has approved Leqembi (lecanemab), the first Alzheimer’s treatment in Canada aimed at the disease’s biology for people with early symptoms—we outline access and safety considerations. We also explain how loneliness raises dementia risk and ways to stay connected, recap our team’s week at AAIC in Toronto, celebrate Dr. Jenny Rabin’s promotion to Associate Professor, and share progress toward our 300-participant goal.